blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2294061

EP2294061 - DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  23.10.2015
Database last updated on 03.10.2024
Most recent event   Tooltip23.10.2015Application deemed to be withdrawnpublished on 25.11.2015  [2015/48]
Applicant(s)For all designated states
Eli Lilly & Company
Lilly Corporate Center
Indianapolis, IN 46285 / US
[2011/11]
Inventor(s)01 / HIPSKIND, Philip, Arthur
Eli Lilly and Company Lilly Corporate Center
Indianapolis, IN 46285 / US
02 / WILSON, Takako
Eli Lilly and Company Lilly Corporate Center
Indianapolis, IN 46285 / US
 [2011/11]
Representative(s)Bassinder, Emma Marie
Eli Lilly and Company Limited
8 Arlington Square West Downshire Way
Bracknell, Berkshire RG12 1PU / GB
[N/P]
Former [2011/11]Bassinder, Emma Marie
Eli Lilly and Company Limited European Patent Operations Lilly Research Centre, Erl Wood Manor Sunninghill Road
Windlesham, Surrey GU20 6PH / GB
Application number, filing date09739376.301.04.2009
[2011/11]
WO2009US39065
Priority number, dateUS2008004872929.04.2008         Original published format: US 48729
[2011/11]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009134574
Date:05.11.2009
Language:EN
[2009/45]
Type: A2 Application without search report 
No.:EP2294061
Date:16.03.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 05.11.2009 takes the place of the publication of the European patent application.
[2011/11]
Search report(s)International search report - published on:EP04.09.2014
ClassificationIPC:C07D401/04, A61K31/502, A61P35/00
[2011/11]
CPC:
C07D401/04 (EP,US); A61P35/00 (EP); A61P43/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/11]
TitleGerman:VERTEILTE PHTHALAZIN-HEDGEHOG-SIGNALWEG-ANTAGONISTEN[2011/11]
English:DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS[2011/11]
French:ANTAGONISTES DE LA VOIE DE LA PROTÉINE HEDGEHOG DE PHTALAZINE DISUBSTITUÉE[2011/11]
Entry into regional phase29.11.2010National basic fee paid 
Examination procedure05.03.2015Application deemed to be withdrawn, date of legal effect  [2015/48]
03.06.2015Despatch of communication that the application is deemed to be withdrawn, reason: filing fee / search fee not paid in time  [2015/48]
Fees paidRenewal fee
02.05.2011Renewal fee patent year 03
02.05.2012Renewal fee patent year 04
02.05.2013Renewal fee patent year 05
30.04.2014Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.04.201507   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DA]WO2005033288  (UNIV JOHNS HOPKINS [US], et al) [DA] 1-12 * claims 13,14,31,37,39,42,45 *;
 [A]WO2006028958  (GENENTECH INC [US], et al) [A] 1-12 * claim - *;
 [PA]WO2008110611  (NOVARTIS AG [CH], et al) [PA] 1-12* claim - *;
 [PA]WO2009002469  (AMGEN INC [US], et al) [PA] 1-12 * claim -; compounds E.G. 2, 75 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.